The New York Entrepreneur

Cidara Therapeutics shares surge 30% after reacquiring flu treatment

Read Time:5 Second

Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post A new wave of e-commerce disruption could close 45,000 retail stores over the next five years, analysts say
Next post Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data